Syros Pharmaceuticals, Inc. Business Finance Contracts & Agreements

Second Amendment to Loan and Security Agreement, dated August 31, 2022, by and among the Registrant and Oxford Finance LLC, as collateral agent and lender (Filed With SEC on November 14, 2022)

Amendment to Loan and Security Agreement, dated July 3, 2022, by and among Syros Pharmaceuticals, Inc. and Oxford Finance LLC, as collateral agent and lender (Filed With SEC on July 5, 2022)

Registration Rights Agreement, dated July 3, 2022, by and among Syros Pharmaceuticals, Inc., 667, L.P. and Baker Brothers Life Sciences, L.P (Filed With SEC on July 5, 2022)

Registration Rights Agreement, dated July 3, 2022, by and among Syros Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on July 5, 2022)

Securities Purchase Agreement, dated July 3, 2022, by and among Syros Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on July 5, 2022)

Form of Pre-Funded Warrant (Filed With SEC on July 5, 2022)

Form of Warrant to Purchase Common Stock or Pre-Funded Warrants (Filed With SEC on July 5, 2022)

Form of Nonstatutory Stock Option Agreement for Inducement Awards (Filed With SEC on October 13, 2021)

Underwriting Agreement, dated January 19, 2021, by and among Syros Pharmaceuticals, Inc., Cowen and Company, LLC and Piper Sandler & Co., as representatives of the several... (Filed With SEC on January 20, 2021)

Registration Rights Agreement, dated December 4, 2020, by and among Syros Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on December 7, 2020)

Securities Purchase Agreement, dated December 4, 2020, by and among Syros Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on December 7, 2020)

Form of Pre-Funded Warrant (Filed With SEC on December 7, 2020)

Form of Warrant to Purchase Common Stock or Pre-Funded Warrants (Filed With SEC on December 7, 2020)

Asset Purchase Agreement, dated as of December 4, 2020, by and between Syros Pharmaceuticals, Inc. and Orsenix, LLC (Filed With SEC on December 7, 2020)

Loan and Security Agreement, dated February 12, 2020, by and among Syros Pharmaceuticals, Inc. and Oxford Finance LLC, as collateral agent and lender (Filed With SEC on February 13, 2020)

Form of Series A Convertible Preferred Stock Certificate (Filed With SEC on April 8, 2019)

Form of Class A Warrant (Filed With SEC on April 8, 2019)

Underwriting Agreement relating to the Preferred Offering, dated April 5, 2019, by and among Syros Pharmaceuticals, Inc., Cowen and Company, LLC and Piper Jaffray & Co., as... (Filed With SEC on April 8, 2019)

Underwriting Agreement relating to the Common Offering, dated April 5, 2019, by and among Syros Pharmaceuticals, Inc., Cowen and Company, LLC and Piper Jaffray & Co., as... (Filed With SEC on April 8, 2019)

Stock Purchase Agreement dated January 8, 2018 by and between the Registrant and Incyte Corporation, as amended (Filed With SEC on March 12, 2018)

Underwriting Agreement, dated January 30, 2018, by and among Syros Pharmaceuticals, Inc., J.P. Morgan Securities LLC, Cowen and Company, LLC and Piper Jaffray & Co., as... (Filed With SEC on January 31, 2018)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 21, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 21, 2017)

[Number of Shares] SYROS PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 20, 2016)